Business Wire

MultiBank Exchange Group Obtains BaFin License and Expands Its Business through Acquisition and Aggressive Growth

Jaa

MultiBank Exchange Group (“MultiBank Group”) announced today that is has secured the German Financial Regulator’s approval to acquire 100% shares of MEX Asset Management GmbH and is now in the process of establishing its European headquarters in Frankfurt, Germany. The new European headquarter of MultiBank Group in Frankfurt has been planned since early 2017, and will have a particular focus on the DACH countries (Germany, Austria and Switzerland), offering a unique suite of financial services and innovative products.

This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171205006513/en/

MultiBank Exchange Group Worldwide Presence (Graphic: Business Wire)

MultiBank Exchange Group Worldwide Presence (Graphic: Business Wire)

Commencing early 2017, MultiBank Group has concentrated its efforts and resources to increase its regulatory status and expand into Europe and other jurisdictions. The regulatory expansion resulted in the addition of new licenses through MEX Asset Management GmbH in Germany (regulated by BaFin), MultiBank FX International in the British Virgin Islands (regulated by the FSC) and MEX Wealth Management Limited in the Cayman Islands (registered with CIMA), making MultiBank Group one of the most regulated online financial derivatives company in the industry.

Given the upcoming Brexit and the forthcoming MIFID 2 regulations going live in January 2018, which is likely to cause substantial changes in Europe’s regulatory environment, particularly the restrictions which will be placed on FCA regulated firms to passport into Europe, the Board of MultiBank Group has resolved to suspend its UK operations and operate its European business through its new European headquarter in Frankfurt, Germany. Previously, the Group conducted business in the UK through MEX (Europe) Limited, which is ultimately owned by Marcus Cumberland. This business relationship with MEX (Europe) Limited has been terminated. By establishing its European headquarter in Frankfurt, MultiBank Group is leading the initiative in the forex and asset management markets, and join other financial institutions such as Goldman Sachs, JP Morgan and Morgan Stanley, to shift their operations from the UK to mainland Europe.

In line with its achievements in expansion and product diversification in Europe, MultiBank Group launched its index on the Frankfurt Stock Exchange under the name of MultiBank Index (ISN XS1633062127) in July 2017 at a par value of 1,000 EUR. The MultiBank Index started trading on September 8, 2017 and to date has surged to a value of over 1,155 EUR, producing a phenomenal increase of close to 16%.

The Chairman of MultiBank Group, Mr. Naser Taher, stated, “Our expansion in Germany, the Cayman Islands and the British Virgin Islands is just the beginning of establishing MultiBank Exchange Group as an absolute market leader in financial regulations, cutting-edge products and innovative financial technology. I say this is just the beginning because, in fact, MultiBank Exchange Group is currently in the process of establishing further regulated entities and subsidiaries in the UAE, Spain and Uruguay, in addition, of course, to continued expansion in the DACH countries.

MultiBank Exchange Group
www.mexgroup.com

MultiBank was established in California, USA in 2005. Since its launch MultiBank has evolved into one of the largest online financial derivatives providers worldwide. Combining prime liquidity, cutting edge technology and first-class customer service, MultiBank delivers advanced trading platforms and tight pricing in online financial products, including Foreign Exchange, Metals Stocks and CFDs. In 2016, MultiBank achieved a notional turnover in excess of US$1.57 trillion in financial derivatives trading from a client-base of over 280,000 participants stretching across 90 countries worldwide. With over 550 employees worldwide, MultiBank maintains offices in Hong Kong, Sydney, Frankfurt, Madrid, Dubai, Beijing, Tianjin, Hangzhou, Ho Chi Minh City, Limassol (Cyprus) and others.

Contact information

Sophia Barnes, +86 10 5921 9300
Marketing Manager
sophia@mexgroup.com

Tietoja julkaisijasta

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tilaa tiedotteet sähköpostiisi

Haluatko tietää asioista ensimmäisten joukossa? Kun tilaat mediatiedotteemme, saat ne sähköpostiisi välittömästi julkaisuhetkellä. Tilauksen voit halutessasi perua milloin tahansa.

Lue lisää julkaisijalta Business Wire

Manchester United and True Religion Launch Denim Range19.10.2018 20:37Tiedote

Manchester United (NYSE:MANU) and luxury denim brand True Religion have collaborated to launch a range of premium club branded denim wear. A first for the club, the new global partnership with the iconic American denim brand will see a range of men’s & women’s co-branded styles go on sale beginning 26th October in the club’s Megastore as well as online via United Direct and truereligion.com & eu.truereligion.com. The exclusive collection features jeans, shirts and jackets, including a highly desirable limited edition denim jacket embroidered with the club’s crest. Fans will have the opportunity to win a selection of clothing from the new range by visiting www.manutd.com/truereligion. Manchester United’s Group Managing Director, Richard Arnold, comments: “True Religion is a well-known, established name in fashion, creating unique designs without compromising on quality. The range we have collaborated on includes the same attention to detail and craftsmanship that has made True Religion

Arch Insurance Announces Strategic Leadership Changes19.10.2018 16:10Tiedote

Arch Insurance today announced that Matt Shulman will assume the newly created role of CEO, Arch Insurance North America, effective January 1, 2019. In this role, he will lead Arch Insurance’s operations in the United States and Canada. He will report to Nicolas Papadopoulo, Chairman and CEO of Arch Worldwide Insurance Group. Mr. Shulman, who has more than 20 years of experience in the insurance industry, has been with Arch Insurance since 2009 and has served as the President and CEO of Arch Insurance Europe since 2016. “Matt brings significant U.S. and international experience to this role. Under his leadership, together with our senior team, Arch Insurance will continue to enhance our value proposition to our customers through a robust, diversified product portfolio, creative solutions and excellent service,” Mr. Papadopoulo said. Arch Insurance has also created a new organizational structure with three Chief Underwriting Officers (CUO) dedicated to specific lines of business. These

Takeda to Present Results from Phase 3 ALTA-1L Trial Highlighting Intracranial Efficacy of ALUNBRIG® (brigatinib) Versus Crizotinib in First-Line Advanced ALK+ Non-Small Cell Lung Cancer19.10.2018 15:00Tiedote

Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that intracranial efficacy data from the Phase 3 ALTA-1L (ALK in Lung Cancer Trial of BrigAtinib in 1 st Line) trial showed improved intracranial progression-free survival (PFS) and intracranial objective response rate (ORR) with ALUNBRIG (brigatinib) compared to crizotinib among anaplastic lymphoma kinase-positive (ALK+) non-small cell lung cancer (NSCLC) patients. Data for these secondary endpoints will be presented in a poster discussion at the European Society for Medical Oncology (ESMO) 2018 Congress on Friday, October 19 at 2:00 p.m. CET in Munich, Germany. These results further support ALUNBRIG as a potential treatment for adults with ALK+ locally advanced or metastatic NSCLC who had not received a prior ALK inhibitor. ALUNBRIG is currently not approved as first-line therapy for advanced ALK+ NSCLC. “ALK+ NSCLC often spreads to the brain, so having options that can clearly demonstrate efficacy both in the brain an

Vertex Receives European CHMP Positive Opinion for KALYDECO® (ivacaftor) to Treat Patients With Cystic Fibrosis Aged 12 to <24 months With Certain Mutations in the CFTR Gene19.10.2018 14:54Tiedote

Vertex Pharmaceuticals (Europe) Limited today announces that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for KALYDECO® (ivacaftor) to include the treatment of people with cystic fibrosis (CF) aged 12 to <24 months who have at least one of the following nine mutations in their cystic fibrosis transmembrane conductance regulator (CFTR) gene: G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N or S549R. If the European Commission issues a favorable adoption of the EMA CHMP opinion for the extension of indication, ivacaftor will be the first and only medicine approved in Europe to treat the underlying cause of CF in patients aged 12 to <24 months, who have specific mutations in the CFTR gene. “Cystic fibrosis is a chronic, progressive disease that is present at birth, with symptoms often occurring in infancy, so early treatment is crucial to deliver the best possible outcomes for patients,” said Reshma Kewalr

Tradeshift Announces Q3 2018 Results19.10.2018 14:00Tiedote

Tradeshift, the leader in supply chain payments and marketplaces, today announced results from the third quarter of 2018, marking the tenth quarter in a row of successive growth and beating targets. Tradeshift’s third quarter growth stats announced today include: YoY revenue grew 400 percent (trailing 12 months) YoY new bookings grew 284 percent YoY gross merchandise volume (GMV) grew 262 percent New total contract value grew by $47M in Q3 Tradeshift’s customer roster continued strong growth this quarter adding 27 new customers, including Hertz, Shiseido, ECU, and Fortune 500 leaders in retail apparel, agriculture, engineering and construction, hospitality, travel and food delivery. Tradeshift also expanded its app ecosystem by adding a key partnership with Coface, a global credit insurer. Coface has announced a new app solution on the Tradeshift platform offering risk and business information services to help businesses make decisions by ensuring greater financial transparency between

Schlumberger Announces Third-Quarter 2018 Results19.10.2018 14:00Tiedote

Schlumberger Limited (NYSE: SLB) today reported results for the third quarter of 2018. (Stated in millions, except per share amounts) Three Months Ended Change Sept. 30, 2018 Jun. 30, 2018 Sept. 30, 2017 Sequential Year-on-year Revenue $8,504 $8,303 $7,905 2% 8% Pretax operating income $1,152 $1,094 $1,059 5% 9% Pretax operating margin 13.5% 13.2% 13.4% 36 bps 15 bps Net income - GAAP basis $644 $430 $545 50% 18% Net income, excluding charges & credits* $644 $594 $581 8% 11% Diluted EPS - GAAP basis $0.46 $0.31 $0.39 48% 18% Diluted EPS, excluding charges & credits* $0.46 $0.43 $0.42 7% 10% North America revenue $3,189 $3,139 $2,602 2% 23% International revenue $5,215 $5,065 $5,147 3% 1% North America revenue, excluding Cameron $2,572 $2,546 $2,086 1% 23% International revenue, excluding Cameron $4,559 $4,387 $4,430 4% 3% *These are non-GAAP financial measures. See section below entitled "Charges & Credits" for details. Schlumberger Chairman and CEO Paal Kibsgaard commented, “Our third

Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.

Tutustu uutishuoneeseemme